Filing Manager
Philotimo Fund, LP
Reporting Manager
Kanen David
Symbol
QIPT
Shares outstanding
43,875,614 shares
Disclosed Ownership
1,930,527 shares
Ownership
4.4%
Form type
SCHEDULE 13D/A
Filing time
28 May 2025, 16:37:12 UTC
Date of event
20 May 2025
Previous filing
04 Mar 2025

Key filing fact

Philotimo Fund, LP disclosed 4.4% ownership in Quipt Home Medical Corp. Common Shares, without Par Value (QIPT) on 20 May 2025.

Key facts

  • Philotimo Fund, LP filed SCHEDULE 13D/A for Quipt Home Medical Corp. Common Shares, without Par Value (QIPT).
  • Disclosed ownership: 4.4%.
  • Date of event: 20 May 2025.

Change

  • Previous schedule filing date: 04 Mar 2025.
  • Current filing was accepted on 28 May 2025, 16:37.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Philotimo Fund, LP 1.8% 786,453 0 786,453 /s/ David L. Kanen David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its general partner 0001688522
Philotimo Focused Growth & Income Fund 2.5% 1,072,491 0 1,072,491 /s/ David L. Kanen David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its investment adviser 0001962162
Kanen Wealth Management LLC 4.4% 1,928,225 0 1,928,225 /s/ David L. Kanen David L. Kanen, Managing Member 0001681614
Kanen David 4.4% 1,930,527 2,302 1,928,225 /s/ David L. Kanen David L. Kanen 0001681743
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .